Overview

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, placebo-controlled, and active controlled clinical trial to assess the efficacy and safety of ZSP1273 tablets in the treatment of Acute Uncomplicated influenza A.
Phase:
Phase 3
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd
Treatments:
Oseltamivir